Drug Shortage Report for TRI-CIRA 21
Report ID | 188979 |
Drug Identification Number | 02508087 |
Brand name | TRI-CIRA 21 |
Common or Proper name | NORGESTIMATE / ETHINYL ESTRADIOL |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE |
Strength(s) | 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 21 BLS |
ATC code | G03AB |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-04-04 |
Estimated end date | 2023-08-08 |
Actual end date | 2023-08-11 |
Shortage status | Resolved |
Updated date | 2023-08-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2023-08-12 | French | Compare |
v11 | 2023-08-12 | English | Compare |
v10 | 2023-08-04 | French | Compare |
v9 | 2023-08-04 | English | Compare |
v8 | 2023-07-27 | French | Compare |
v7 | 2023-07-27 | English | Compare |
v6 | 2023-07-21 | French | Compare |
v5 | 2023-07-21 | English | Compare |
v4 | 2023-06-23 | French | Compare |
v3 | 2023-06-23 | English | Compare |
v2 | 2023-04-06 | French | Compare |
v1 | 2023-04-06 | English | Compare |
Showing 1 to 12 of 12